Table 5.

Summary of H pylori and ITP data: review of the literature


Source of data, first author

Pts origin, mean (range) or median (SC) age, y

No. of pts with ITP tested (no. with chronic ITP)

No. of pts Hp+ (% of pts with ITP)

Method(s) used to detect Hp

Mean (SD) or median (range) plt count × 109/L in Hp+ pts at inclusion

No. treated for Hp (no. with plts < 30 × 109/L)

No. of pts whose Hp was eradicated (% of pts treated)

Nos. of PR or CR in pts whose Hp was eradicated (%)

Mean (SD) or median (range) follow-up time after treatment, mos

Comments
Gasbarrini   Italian 45 (±14)   18 (NA)   11 (61.1)   Breath test   95 (±39)   11 (0)   8 (72.7)   8/8 (100)   4 (NA)   None of the patients had marked thrombocytopenia before eradication  
Emilia   Italian 50 (17-89)   30 (30)   13 (43.3)   Breath test, histol   53 (±23.5)   13 (3)   12 (92.3)   6/12 (50)   8.3 (6-12)  Hp was more frequent in men. In an updated follow-up (median of 31.1 mos), 1 patient relapsed.  
Veneri   Italian (NA)   35 (NA)   25 (71.4)   Breath test, histol   51 (±28)   16 (4)   15 (93.6)   11/15 (73.3)   11.7 (6-28)   Two patients with severe chronic ITP responded.  
Kohda   Japanese 52.7 (24-80)   48 (40)   25 (62.5)   Breath test, histol, serum Abs   67 (±54)   19 (NA)   19 (100.0)   12/19 (63)   14.8 (9-39)   No change in plt count in Hp+ untreated patients. Six of 8 patients with refractory ITP responded.  
Hashino   Japanese (NA)   22 (22)   14 (63.6)   Histol + culture   (NA)   14 (NA)   13 (82.9)   5/13 (38.4)   15 (NA)   One patient who had an initial complete response relapsed without Hp reinfection.  
Hino   Japanese 54 (26-84)   30 (25)   21 (70.0)   Breath test, serum Abs   32 (±19.75)   21 (7)   18 (85.7)   10/18 (55.6)   NA   Three Hp- patients were treated without plt count increase.  
Michel   French 40 (±19.8)   51 (42)   15 (29.4)   Serum Abs   13 (1-50)   None treated   —   —   —  Hp prevalence was similar in controls. No differences were found between Hp+ and Hp- patients. The effect of eradication was not tested.  
Jarque   Spanish (NA)   56 (56)   40 (71.4)   Breath test   57 (±22)   32 (NA)   23 (71.9)   3/23 (13)   Response assessed after 3 mos   Response rates were similar in Hp+ and Hp- patients.  
This report   White, Hispanics 41 (± 18.3)   74 (67)   16 (21.6)   Breath test   34 (10-54)   15 (7)   14 (93.3)   1/14 (7)   11.5 (3-18)   Eradication therapy also ineffective in 10 Hp- patients.  
Total
 

 
364
 
180 (49.5)
 

 

 
141
 
122 (86.5)
 
56/122 (46)
 

 

 

Source of data, first author

Pts origin, mean (range) or median (SC) age, y

No. of pts with ITP tested (no. with chronic ITP)

No. of pts Hp+ (% of pts with ITP)

Method(s) used to detect Hp

Mean (SD) or median (range) plt count × 109/L in Hp+ pts at inclusion

No. treated for Hp (no. with plts < 30 × 109/L)

No. of pts whose Hp was eradicated (% of pts treated)

Nos. of PR or CR in pts whose Hp was eradicated (%)

Mean (SD) or median (range) follow-up time after treatment, mos

Comments
Gasbarrini   Italian 45 (±14)   18 (NA)   11 (61.1)   Breath test   95 (±39)   11 (0)   8 (72.7)   8/8 (100)   4 (NA)   None of the patients had marked thrombocytopenia before eradication  
Emilia   Italian 50 (17-89)   30 (30)   13 (43.3)   Breath test, histol   53 (±23.5)   13 (3)   12 (92.3)   6/12 (50)   8.3 (6-12)  Hp was more frequent in men. In an updated follow-up (median of 31.1 mos), 1 patient relapsed.  
Veneri   Italian (NA)   35 (NA)   25 (71.4)   Breath test, histol   51 (±28)   16 (4)   15 (93.6)   11/15 (73.3)   11.7 (6-28)   Two patients with severe chronic ITP responded.  
Kohda   Japanese 52.7 (24-80)   48 (40)   25 (62.5)   Breath test, histol, serum Abs   67 (±54)   19 (NA)   19 (100.0)   12/19 (63)   14.8 (9-39)   No change in plt count in Hp+ untreated patients. Six of 8 patients with refractory ITP responded.  
Hashino   Japanese (NA)   22 (22)   14 (63.6)   Histol + culture   (NA)   14 (NA)   13 (82.9)   5/13 (38.4)   15 (NA)   One patient who had an initial complete response relapsed without Hp reinfection.  
Hino   Japanese 54 (26-84)   30 (25)   21 (70.0)   Breath test, serum Abs   32 (±19.75)   21 (7)   18 (85.7)   10/18 (55.6)   NA   Three Hp- patients were treated without plt count increase.  
Michel   French 40 (±19.8)   51 (42)   15 (29.4)   Serum Abs   13 (1-50)   None treated   —   —   —  Hp prevalence was similar in controls. No differences were found between Hp+ and Hp- patients. The effect of eradication was not tested.  
Jarque   Spanish (NA)   56 (56)   40 (71.4)   Breath test   57 (±22)   32 (NA)   23 (71.9)   3/23 (13)   Response assessed after 3 mos   Response rates were similar in Hp+ and Hp- patients.  
This report   White, Hispanics 41 (± 18.3)   74 (67)   16 (21.6)   Breath test   34 (10-54)   15 (7)   14 (93.3)   1/14 (7)   11.5 (3-18)   Eradication therapy also ineffective in 10 Hp- patients.  
Total
 

 
364
 
180 (49.5)
 

 

 
141
 
122 (86.5)
 
56/122 (46)
 

 

 

Pts indicates patients; SD, standard deviation; Hp, H pylori; plt, platelet; PR/CR, partial or complete response according to the author criteria; mos, months; NA, data not available; histol, H pylori infection confirmed by histology; Abs, specific anti-H pylori antibodies (IgG); and—, not applicable.

or Create an Account

Close Modal
Close Modal